Stock Markets: Nyse

GAIN Capital Announces Monthly Metrics for March 2018

BEDMINSTER, N.J., April 6, 2018 -- GAIN Capital Holdings, Inc. (NYSE: GCAP) ("GAIN" or "the Company") today reported certain operating metrics for the month of March 2018. Mar-18 Feb-18 Mar-17 Sequential Change Year-over-year change Retail Segment OTC Trading Volume(1) $ 262.8 $ 283.5 $ 239.2 (7.3)% 9.9% OTC Average Daily Volume $ 11.9 $ 14.2 $ 10.4 (16.2)% 14.4% 12 Month Trailing Active OTC Accounts(2) 131,764 133,545 136,829 (1.3)% (3.7)% 3...

Published on .

Washington Prime Group to Transform Department Store Space at Southern Park Mall

COLUMBUS, Ohio, April 06, 2018 -- Washington Prime Group Inc. (NYSE:WPG) today announced its most recent redevelopment effort, a multi-million dollar project anchored by the addition of diversified tenants at Southern Park Mall, a Tier One asset located in Youngstown, Ohio.The Company is in discussions with new tenants, which will be announced in the future, for the high visibility anchor space currently occupied by Sears. The Company proactively negotiated an early termination of the lease to gain...

Published on .

EyeGate Completes Enrollment and Receives Milestone Payment for Confirmatory Phase 3 Clinical Study of EGP-437 in Anterior Uveitis

WALTHAM, Mass., April 06, 2018 -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or the “Company”), today announced completion of patient enrollment for the pivotal Phase 3 clinical study of its EGP-437 combination product for the treatment of non-infectious anterior uveitis.Non-infectious anterior uveitis is characterized by the inflammation of the anterior chamber of the eye. Symptoms may include redness, soreness and inflammation of the eye, blurring of vision, sensitivity to light...

Published on .

Shellye L. Archambeau Joins Roper Technologies Board of Directors

SARASOTA, Fla., April 06, 2018 -- Roper Technologies, Inc. (NYSE:ROP), a diversified technology company, announced that Shellye L. Archambeau has been elected to its Board of Directors.  Ms. Archambeau most recently served as Chief Executive Officer of MetricStream, Inc., a global provider of governance, risk, compliance and quality management solutions across diverse industries.  Prior to joining MetricStream, Ms. Archambeau served as Chief Marketing Officer and Executive Vice President...

Published on .

Orbital ATK-Built HYLAS 4 Commercial Communications Satellite Successfully Launched

DULLES, Va.--(BUSINESS WIRE)--Orbital ATK (NYSE: OA), a global leader in aerospace and defense technologies, today announced the HYLAS 4 commercial communications Ka-band satellite, built by the company for Avanti Communications Group plc (Avanti), was successfully launched aboard an Arianespace rocket. HYLAS 4 is the third GEOStar-3™ satellite to be completed by Orbital ATK and will provide high speed and affordable broadband communications to Europe and Africa. Liftoff occurred at 5:34 p.m. EDT...

Published on .

AbbVie to Host First-Quarter 2018 Earnings Conference Call

NORTH CHICAGO, Ill., April 6, 2018 -- AbbVie (NYSE: ABBV) will announce its first-quarter 2018 financial results on Thursday, Apr. 26, 2018, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern). It will be accessible through AbbVie's Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day. About AbbVie AbbVie is a global, research-driven biopharmaceutical...

Published on .

Hormel Foods Honors 90 Suppliers with Spirit of Excellence Award

AUSTIN, Minn., April 6, 2018 -- Hormel Foods Corporation (NYSE: HRL) recently awarded 90 suppliers with a 2017 Spirit of Excellence Award for their roles in the company's continuous improvement process throughout the last year. These suppliers are from a variety of areas including contractors, pork procurement, provisions, ingredients, packaging and transportation. "We are proud to partner with these outstanding suppliers and congratulate them on this achievement," said Curtis Southard,...

Published on .

Valeant Will Release First-Quarter 2018 Financial Results On May 8

LAVAL, Quebec, April 6, 2018 -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ("Valeant") will release its first-quarter 2018 financial results on Tuesday, May 8, 2018. Valeant will host a conference call and live web cast at 8:00 a.m. EDT to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Valeant web site prior to the start of the call. Conference Call Details Date: Tuesday, May...

Published on .

Adaptimmune to Present Two Posters at the Upcoming American Association for Cancer Research (AACR) Annual Meeting

PHILADELPHIA, Pa. and OXFORD, U.K., April 06, 2018 -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, will present two posters summarizing preclinical research with its MAGE-A4 and MAGE-A10 SPEAR T-cells at the upcoming AACR meeting at McCormick Place in Chicago, Illinois.Session, date, time, and location (for both posters):Session Category (Title): Clinical Research (Adoptive Cell Therapy 2)Date: Monday Apr 16, 2018Time: 1:00 PM - 5:00 PM (CDT)Location:...

Published on .

FTE Networks to Report Fourth Quarter and Full Year 2017 Financial Results on April 17, 2018

NAPLES, Fla., April 06, 2018 -- FTE Networks, Inc. (NYSE American:FTNW) ("FTE" or the "Company"), a leading provider of innovative technology-oriented solutions for smart platforms, network infrastructure and intelligent buildings, today announced that it will report its financial results for the three-month period and year ended December 31, 2017 on Tuesday, April 17, 2018, after the market close.The Company will host a conference call with the investment community the following morning on Wednesday,...

Published on .

Impax Launches a Generic Version of Estrace® Cream (estradiol vaginal cream, USP, 0.01%)

BRIDGEWATER, N.J., April 6, 2018 -- Impax Laboratories, Inc. (NASDAQ: IPXL), a specialty pharmaceutical company, today announced it has launched a generic version of Estrace® Cream (estradiol vaginal cream, USP, 0.01%).  Impax's manufacturing and development partner, Perrigo Company plc (NYSE; TASE: PRGO), received final approval from the U.S. Food and Drug Administration in late January.  Estrace® Cream had annual U.S. sales of approximately $469 million according to IQVIA®...

Published on .

Rabobank désensibilise ses données clients pour le RGPD et DevOps avec IBM

UTRECHT, Pays-Bas, 6 avril 2018 -- Rabobank, la société multinationale néerlandaise de services bancaires et financiers, collabore avec IBM (NYSE : IBM) pour utiliser des pseudonymes cryptographiques sur les données personnelles de ses clients dans le but d'innover et de respecter les nouvelles règles financières en vigueur dans l'Union européenne.À compter du 25 mai, le Règlement général sur la protection des données (RGPD) visera la création d'un cadre...

Published on .